Auxly Cannabis Group Inc. (TSX.V - XLY)
("
Auxly" or the “
Company”), a
leading consumer packaged goods company in the derivative cannabis
market, is pleased to announce that its wholly-owned subsidiary
Dosecann LD Inc. (“
Dosecann”) has entered into an
agreement with Medical Cannabis by Shoppers Drug Mart Inc.
(“
Shoppers”), a subsidiary of Shoppers Drug Mart
Inc., to become a supplier of cannabis products through its online
platform. The agreement will see Auxly’s suite of products and
brands, including chewables, chocolates, vapes and oil in a bottle,
all developed and manufactured at Dosecann, available to consumers
across Canada. Dosecann has completed its initial shipment of
cannabis products to Shoppers.
“Having our diverse cannabis product offering
with Shoppers allows us to reach a wide group of patients across
the country with our quality, science-backed products,” said Hugo
Alves, CEO of Auxly. “We are proud to partner with Shoppers and
look forward to bringing their customers our products, built on
Dosecann’s pillars of quality, safety and efficacy.”
Greg Boone, CEO of Dosecann, added: “Our team at
Dosecann prides itself on manufacturing products backed by science
and advanced research and development to ensure that consumers get
the high-quality cannabis products that they need. We think this
achievement is a testament to the extraordinary team that we’ve
assembled and the rigor and precision that we apply to product
development and manufacturing.”
The agreement is for a three-year term, subject
to renewal for an additional two years.
ON BEHALF OF THE BOARD
"Hugo Alves" CEO
About Dosecann LD Inc.
Dosecann, a wholly-owned subsidiary of Auxly, is
a Canadian developer and manufacturer of innovative cannabis
products for the wellness-focused consumer. Dosecann is committed
to providing Canadians with quality products designed for everyday
use, backed by science and advanced research. Dosecann’s 52,000
square foot, GMP-compliant facility located in Charlottetown,
Prince Edward Island, houses extraction, research and development,
product formulation, analytical testing and commercial
manufacturing for Auxly’s branded cannabis products. Built on the
pillars of quality, safety and efficacy, Dosecann is cannabis –
down to a science™.
About Auxly Cannabis Group Inc. (TSX.V:
XLY) (OTCQX: CBWTF)
Auxly is an international cannabis company
dedicated to bringing innovative, effective, and high-quality
cannabis products to the medical, wellness and adult-use markets.
Auxly's experienced team of industry first-movers and enterprising
visionaries has secured a diversified supply of raw cannabis,
strong clinical, scientific and operating capabilities and leading
research and development infrastructure in order to create trusted
products and brands in an expanding global market.
Learn more at www.auxly.com and stay up to date at Twitter:
@AuxlyGroup; Instagram: @auxlygroup; Facebook:
@auxlygroup; LinkedIn: company/auxlygroup/.
Investor Relations:For investor
enquiries please contact our Investor Relations Team: Email:
IR@auxly.comPhone: 1.833.695.2414
Media Enquiries
(only):
For media enquiries or to set up an interview
please contact:Email: press@auxly.com
Notice Regarding Forward Looking
Information:
This news release contains certain
"forward-looking information" within the meaning of applicable
Canadian securities law. Forward-looking information is frequently
characterized by words such as "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed" and other similar words, or
information that certain events or conditions "may" or "will"
occur. This information is only a prediction. Various assumptions
were used in drawing the conclusions or making the projections
contained in the forward-looking information throughout this news
release. Forward-looking information includes, but is not limited
to: Auxly's execution of its product development and
commercialization strategy, consumer preferences, political change,
future legislative and regulatory developments involving cannabis
and cannabis products; and competition and other risks affecting
Auxly and Dosecann in particular and the cannabis industry
generally.
A number of factors could cause actual results
to differ materially from a conclusion, forecast or projection
contained in the forward-looking information in this release
including, but not limited to whether: Dosecann is able to maintain
its current licences and obtain and maintain all other necessary
governmental and regulatory authorizations and permits to conduct
business, the acceptance and demand for future Dosecann products by
consumers, and general economic, financial market, regulatory and
political conditions in which Auxly and Dosecann operate will
remain the same. Additional risk factors are disclosed in the
revised annual information form of Auxly for the financial year
ended December 31, 2017 dated May 24, 2018.
New factors emerge from time to time, and it is
not possible for management to predict all of those factors or to
assess in advance the impact of each such factor on Auxly’s
business or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those
contained in any forward-looking information. The forward-looking
information in this release is based on information currently
available and what management believes are reasonable assumptions.
Forward-looking information speaks only to such assumptions as of
the date of this release. In addition, this release may contain
forward-looking information attributed to third party industry
sources, the accuracy of which has not been verified by Auxly. The
purpose of forward-looking information is to provide the reader
with a description of management's expectations, and such
forward-looking information may not be appropriate for any other
purpose. Readers should not place undue reliance on forward-looking
information contained in this release.
The forward-looking information contained in
this release is expressly qualified by the foregoing cautionary
statements and is made as of the date of this release. Except as
may be required by applicable securities laws, Auxly does not
undertake any obligation to publicly update or revise any
forward-looking information to reflect events or circumstances
after the date of this release or to reflect the occurrence of
unanticipated events, whether as a result of new information,
future events or results, or otherwise.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Auxly Cannabis (TSXV:XLY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Auxly Cannabis (TSXV:XLY)
Historical Stock Chart
From Jul 2023 to Jul 2024